Positron Emission Tomography

1. Front Matter

   Pages i-xiv

   PDF

2. Basic Science of PET and PET/CT

   • David W. Townsend

   Pages 1-16

3. Incremental Value of Imaging Structure and Function

   • Dominique Delbeke

   Pages 17-26

4. The Technologist’s Perspective

   • Bernadette F. Cronin

   Pages 27-40

5. Radiation Protection and Dosimetry in PET and PET/CT

   • Jocelyn E. C. Towson, Stefan Eberl

   Pages 41-62

6. Artifacts and Normal Variants in Whole-Body PET and PET/CT Imaging

   • Gary J. R. Cook

   Pages 63-77

7. PET Imaging in Brain Tumors

   • Terence Z. Wong, R. Edward Coleman

   Pages 79-87

8. PET and PET/CT Imaging in Lung Cancer

   • Pierre Rigo, Roland Hustinx, Thierry Bury

   Pages 89-106

9. PET and PET/CT Imaging in Head and Neck Cancer

   • Val J. Lowe, Brendan C. Stack Jr., Trond V. Bogsrud

   Pages 107-124

10. PET and PET/CT Imaging in Lymphoma

    • Guy H. M. Jerusalem, Roland Hustinx, Pierre Rigo

    Pages 125-145

11. PET and PET/CT Imaging in Colorectal Cancer

    • Christiaan Schiepers, Peter E. Valk

    Pages 147-164

12. PET and PET/CT Imaging in Esophageal and Gastric Cancers

    • Farrokh Dehdashti, Barry A. Siegel

    Pages 165-180

13. PET and PET/CT Imaging in Tumors of the Pancreas and Liver

    • Dominique Delbeke, William H. Martin

    Pages 181-195

14. PET and PET/CT Imaging in Breast Cancer

    • Richard L. Wahl

    Pages 197-215

15. PET and PET/CT Imaging in Testicular and Gynecologic Cancers

    • Sharon F. Hain

    Pages 217-231

16. PET and PET/CT Imaging in Melanoma

    • George M. Segall, Susan M. Swetter

    Pages 233-242

17. PET and PET/CT Imaging in Urologic Tumors

    • Paul D. Shreve

    Pages 243-251

18. PET and PET/CT in Sarcoma

    • Michael J. O’Doherty, Michael A. Smith

    Pages 253-267

19. PET and PET/CT Imaging in Thyroid and Adrenal Diseases

    • I. Ross McDougall

    Pages 269-281

20. PET and PET/CT Imaging in Multiple Myeloma, Solitary Plasmacytoma, MGUS, and Other Plasma Cell Dyscrasias

    • Ronald C. Walker, Laurie B. Jones-Jackson, Erik Rasmussen, Marisa Miceli, Edgardo J. C. Angtuaco, Frits Van Rhee et al.

    Pages 283-302

The use of positron emission tomography (PET) in clinical practice is key to the s- cessful management of many patients with a wide variety of diseases. Whereas in the 1980s and 1990s nuclear medicine physicians struggled to convince other doctors about the potential clinical value of PET, it is now a challenge to keep up with the requests of our clinical colleagues for the various applications of PET. In fact, in most cases the barriers are now related to reimbursement for a given PET procedure. At the time this foreword was written, many FDG/PET procedures are reimbursable, and the U.S. National PET Registry, which is about to be implemented, will allow FDG/PET imaging data to accumulate on rare tumors, while allowing for Center for Medicare and Medicaid Services (CMS) reimbursement. The challenges are now shifting toward solving some of the limitations of FDG/PET through the use of next generation inst- mentation and newer tracers that hold the promise of improving on what is already a remarkable achievement with FDG/PET. It is my hope that there will in fact be an enormous growth of nuclear medicine driven by new imaging tracers that will fuel a growing number of clinical applications.

• Diagnostic Imaging
• Functional Imaging
• PET/CT
• Tumor
• computed tomography (CT)
• imaging
• positron emission tomography
• radiology

• Northern California PET Imaging Center, Sacramento, USA

  Peter E. Valk

• Positron Emission Tomography, Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, USA

  Dominique Delbeke

• Department of Nuclear Medicine, Royal North Shore Hospital, Sydney, Australia

  Dale L. Bailey

• Cancer Imaging and Tracer Development Program, The University of Tennessee Medical Center, Knoxville, USA

  David W. Townsend

• Department of Radiological Sciences, Guy’s and St Thomas’ Clinical PET Centre, Guy’s and St Thomas’ Hospital Trust, London, UK

  Michael N. Maisey

Policies and ethics